Host kinase identified as an inhibition target for SARS-CoV-2
In this experiment, the chemical probe SGC-CK2-1 inhibited virus replication at nanomolar concentration, showing a highly selective effect on the kinase.
Source: news-medical.net
Page 31 - Cell Line News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cell Line. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cell Line Today - Breaking & Trending Today
Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen's AGE1.CR® Vaccine Manufacturing Platform
BERLIN, Germany and NEW YORK, USA, January 06, 2022 / B3C newswire / -- ProBioGen AG is delighted to announce the execution of a service and commercial product license agreement with Imvaq Therapeutics, a biotech company developing innovative cancer immunotherapies. Under this agreement, ProBioGen develops a scalabl...
Source: pharmiweb.com
SARS-CoV-2 VOCs dependent on IFITM2 for efficient infection establishment
Researchers demonstrate that the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 require endogenous IFITM2 expression for efficient replication.
Source: news-medical.net
Sartorius strengthens its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions
The life science group Sartorius is expanding its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions GmbH.
Source: news-medical.net
Providing quick & efficient CRO services with Sino Biological
In this interview, News-Medical talks to Dr. Lin Yutao, head of project management at Sino Biological, about the work she does and how Sino provides quick and efficient recombinant CRO services.
Source: news-medical.net